June 10 – 12, 2024 | Boston, NMA

2024 is shaping up to be a vitally important year for the future of allogeneic cell therapies. With exciting clinical data readouts expected in the coming months and the cell therapy community recognizing autoimmune indications as the promising new cornerstone of research – the tide is shifting for off-the-shelf therapies.

Placing a spotlight on what has been deemed the ‘future of cell therapy’, the 6th Annual Allogeneic Cell Therapies Summit returns to Boston this June as the leading industry-focused meeting dedicated to accelerating the safety, durability, and clinical translation of off-the-shelf therapies to deliver affordable and accessible treatments for patients in critical need.